RBC Capital Downgrades Moderna to Sector Perform, Lowers Price Target to $90
Portfolio Pulse from Benzinga Newsdesk
RBC Capital has downgraded Moderna (NASDAQ:MRNA) from Outperform to Sector Perform and lowered its price target from $125 to $90.
August 05, 2024 | 11:25 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
RBC Capital has downgraded Moderna from Outperform to Sector Perform and reduced the price target from $125 to $90.
The downgrade from Outperform to Sector Perform and the significant reduction in the price target from $125 to $90 by RBC Capital is likely to negatively impact investor sentiment and the stock price of Moderna in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100